0001209191-22-040781.txt : 20220705 0001209191-22-040781.hdr.sgml : 20220705 20220705170053 ACCESSION NUMBER: 0001209191-22-040781 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220705 DATE AS OF CHANGE: 20220705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sharei Armon CENTRAL INDEX KEY: 0001829463 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39662 FILM NUMBER: 221066098 MAIL ADDRESS: STREET 1: C/O SQZ BIOTECHNOLOGIES COMPANY STREET 2: 200 ARSENAL YARDS BOULEVARD, SUITE 210 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SQZ Biotechnologies Co CENTRAL INDEX KEY: 0001604477 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462431115 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., STE. 210 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-898-8824 MAIL ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., STE. 210 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-30 0 0001604477 SQZ Biotechnologies Co SQZ 0001829463 Sharei Armon 200 ARSENAL YARDS BLVD, SUITE 210 WATERTOWN MA 02472 1 1 0 0 President and CEO Common Stock 2022-06-30 5 A 0 E 2436 2.703 A 287884 D The reporting person is voluntarily reporting the acquisition on June 30, 2022 of 2,436 shares of the issuer's common stock pursuant to the issuer's employee stock purchase plan. /s/ Lawrence Knopf, Attorney-in-Fact for Armon Sharei 2022-07-05